BAIRD MEDICAL INVESTMENT HOLDINGS LIMITED
Room
202, 2/F, Baide Building, Building 11, No.15
Rongtong Street, Yuexiu District, Guangzhou, Peoples Republic of China
September 3, 2024
VIA EDGAR
Tracey Houser
Jeanne Baker
Conlon Danberg
Lauren Nguyen
Jane Park
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Re: | Baird Medical Investment Holdings Limited |
Registration Statement on Form F-4 (File
No. 333-274114) |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Baird Medical Investment Holdings Limited (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form F-4 to become effective on Thursday, September 5, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
The Registrant requests that it be notified of such effectiveness by a telephone call to Stephen Leitzell, Esq. of Dechert LLP, counsel to the Registrant, at (215) 994-2621 or by an email to stephen.leitzell@dechert.com.
Thank you for your assistance. If you should have any questions, please contact Mr. Leitzell at (215) 994-2621.
Very truly yours, | |
/s/ Haimei Wu | |
Haimei Wu Chief Executive Officer |